Literature DB >> 25236565

Electrocardiographic changes announcing the rapid development of apical hypertrophic cardiomyopathy in an adult male.

Alfonso Freites1, Ester Canovas1, J Rubio1.   

Abstract

We presented the case of an adult male without structural heart disease, who in the period of 3 years developed apical hypertrophic cardiomyopathy. ECG changes preceded the development of ventricular hypertrophy. We discussed the appearance of ventricular enlargement during adulthood, in some cases of hypertrophic cardiomyopathy (HC), and how the ECG abnormalities may precede the onset of ventricular hypertrophy.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Hypertrophic Cardiomyopathy; MRI; echocardiography; electrocardiography

Mesh：

Year:  2014        PMID： 25236565      PMCID： PMC6931627          DOI： 10.1111/anec.12213

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


  10 in total

Review 1.  American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors:  Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal:  J Am Coll Cardiol       Date:  2003-11-05       Impact factor: 24.094

2.  IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. I. A DESCRIPTION OF THE DISEASE BASED UPON AN ANALYSIS OF 64 PATIENTS.

Authors:  E BRAUNWALD; C T LAMBREW; S D ROCKOFF; J ROSS; A G MORROW
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

3.  Onset of apical hypertrophic cardiomyopathy in adulthood.

Authors:  Barry J Maron; Tammy S Haas; Carrie Kitner; John R Lesser
Journal:  Am J Cardiol       Date:  2011-09-28       Impact factor: 2.778

4.  Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly.

Authors:  Hideshi Niimura; Kristen K Patton; William J McKenna; Johann Soults; Barry J Maron; J G Seidman; Christine E Seidman
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

5.  Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.

Authors:  Neal K Lakdawala; Jens Jakob Thune; Barry J Maron; Allison L Cirino; Ole Havndrup; Henning Bundgaard; Michael Christiansen; Christian M Carlsen; Jean-François Dorval; Raymond Y Kwong; Steven D Colan; Lars V Køber; Carolyn Y Ho
Journal:  Am J Cardiol       Date:  2011-09-21       Impact factor: 2.778

6.  Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.

Authors:  B J Maron; H Niimura; S A Casey; M K Soper; G B Wright; J G Seidman; C E Seidman
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

7.  Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.

Authors:  W J McKenna; J T Stewart; P Nihoyannopoulos; F McGinty; M J Davies
Journal:  Br Heart J       Date:  1990-05

Review 8.  Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.

Authors:  Ronny Alcalai; Jonathan G Seidman; Christine E Seidman
Journal:  J Cardiovasc Electrophysiol       Date:  2007-10-04

9.  The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.

Authors:  S al-Mahdawi; S Chamberlain; L Chojnowska; E Michalak; P Nihoyannopoulos; M Ryan; B Kusnierczyk; J A French; D M Gilligan; J Cleland
Journal:  Br Heart J       Date:  1994-08

10.  Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

Authors:  B J Maron; P Spirito; Y Wesley; J Arce
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.